Universitat Jaume I-ko ikertzaileekin lankidetzan egindako argitalpenak (123)

2021

  1. N-alpha-Aminoacyl Colchicines as Promising Anticancer Agents

    Medicinal chemistry (Shariqah (United Arab Emirates)), Vol. 17, Núm. 1, pp. 21-32

  2. Synthesis of N-acyl derivatives of aminocombretastatin A-4 and study of their interaction with tubulin and downregulation of c-Myc

    Medicinal Chemistry, Vol. 17, Núm. 10, pp. 1129-1139

2020

  1. Synthesis of Combretastatin A-4 and 30-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of their Interaction with Tubulin and as Downregulators of the VEGF, hTERT and c-Myc Gene Expression

    Molecules, Vol. 25, Núm. 3

2019

  1. Arylpyridines, arylpyrimidines and related compounds as potential modulator agents of the VEGF, hTERT and c-Myc oncogenes

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 5, pp. 880-887

  2. Novel multitarget inhibitors with antiangiogenic and immunomodulator properties

    European Journal of Medicinal Chemistry, Vol. 170, pp. 87-98

  3. Synthesis and biological evaluation as antiangiogenic agents of ureas derived from 3′-aminocombretastatin A-4

    European Journal of Medicinal Chemistry, Vol. 162, pp. 781-792

2018

  1. Arylureas derived from colchicine: Enhancement of colchicine oncogene downregulation activity

    European Journal of Medicinal Chemistry, Vol. 150, pp. 817-828

  2. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives

    European Journal of Medicinal Chemistry, Vol. 150, pp. 591-600

  3. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents

    European Journal of Medicinal Chemistry, Vol. 147, pp. 183-193

  4. Synthesis and biological evaluation of cyclic derivatives of combretastatin A-4 containing group 14 elements

    Organic and Biomolecular Chemistry, Vol. 16, Núm. 32, pp. 5859-5870

2017

  1. Interactions of long-chain homologues of colchicine with tubulin

    European Journal of Medicinal Chemistry, Vol. 126, pp. 526-535

  2. Synthesis and Biological Evaluation of Imines Structurally Related to Resveratrol as Dual Inhibitors of VEGF Protein Secretion and hTERT Gene Expression

    Natural Product Communications, Vol. 12, Núm. 5, pp. 699-704

  3. Synthesis and Biological Evaluation of Imines Structurally Related to Resveratrol as Dual Inhibitors of VEGF Protein Secretion and hTERT Gene Expression1

    Natural Product Communications, Vol. 12, Núm. 5

  4. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring

    Organic and Biomolecular Chemistry, Vol. 15, Núm. 1, pp. 220-232

  5. Synthesis of honokiol analogues and evaluation of their modulating action on VEGF protein secretion and telomerase-related gene expressions

    Chemical Biology and Drug Design, Vol. 89, Núm. 4, pp. 577-584

2016

  1. Design, synthesis and antimalarial evaluation of novel thiazole derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 16, pp. 3938-3944

  2. Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions

    Bioorganic and Medicinal Chemistry, Vol. 24, Núm. 14, pp. 3108-3115

2015

  1. Inhibitory effect of cytotoxic nitrogen-containing heterocyclic stilbene analogues on VEGF protein secretion and VEGF, hTERT and c-Myc gene expression

    MedChemComm, Vol. 6, Núm. 10, pp. 1809-1815

  2. Inhibitory effect of cytotoxic stilbenes related to resveratrol on the expression of the VEGF, hTERT and c-Myc genes

    European Journal of Medicinal Chemistry, Vol. 103, pp. 488-496

  3. Inhibitory effect of pironetin analogue/colchicine hybrids on the expression of the VEGF, hTERT and c-Myc genes

    Bioorganic and Medicinal Chemistry Letters, Vol. 25, Núm. 16, pp. 3194-3198